NDC product
Vicks Sinex Severe All in One Sinus Mucus
NDC 37000-951 · The Procter & Gamble Manufacturing Company
Key facts
| Product NDC | 37000-951 |
|---|---|
| Proprietary name | Vicks Sinex Severe |
| Nonproprietary name | Acetaminophen, Phenylephrine HCl, Guaifenesin |
| Substances | PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN |
| Dosage form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Labeler | The Procter & Gamble Manufacturing Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Jul 10, 2018 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: